Literature DB >> 22658293

Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.

Eduardo Aguilar1, Ana María García-Díaz, Juan Francisco Sánchez Muñoz-Torrero, Lorenzo Ramón Alvarez, Mar Piedecausa, Gemma Arnedo, Manuel Monreal.   

Abstract

BACKGROUND: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied.
METHODS: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation.
RESULTS: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 ± 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar.
CONCLUSIONS: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22658293     DOI: 10.1016/j.thromres.2012.05.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.

Authors:  Gilles Lemesle; Gregory Ducrocq; Yedid Elbez; Eric Van Belle; Shinya Goto; Christopher P Cannon; Christophe Bauters; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Clin Cardiol       Date:  2017-07-10       Impact factor: 2.882

Review 2.  Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice.

Authors:  Rohan Shah; Manesh R Patel
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-09-19

Review 3.  Atherosclerosis and Atrial Fibrillation: Double Trouble.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2022-01-06       Impact factor: 2.931

Review 4.  Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies.

Authors:  Mislav Vrsalović; Ana Vrsalović Presečki
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

5.  Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study.

Authors:  Ying Bai; Jun Zhu; Yan-Min Yang; Yan Liang; Hui-Qiong Tan; Juan Wang; Bi Huang; Han Zhang; Xing-Hui Shao
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

6.  Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.

Authors:  Wenqi He; Yingjie Chu
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

7.  Functional Outcome and Safety of Intracranial Thrombectomy After Emergent Extracranial Stenting in Acute Ischemic Stroke Due to Tandem Occlusions.

Authors:  Philipp Bücke; Marta Aguilar Pérez; Muhammad AlMatter; Victoria Hellstern; Hansjörg Bäzner; Hans Henkes
Journal:  Front Neurol       Date:  2018-11-20       Impact factor: 4.003

8.  Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease.

Authors:  Sandro Ninni; Gilles Lemesle; Thibaud Meurice; Olivier Tricot; Nicolas Lamblin; Christophe Bauters
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

9.  Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Authors:  Laurent Fauchier; Nicola Greenlaw; Roberto Ferrari; Ian Ford; Kim M Fox; Jean-Claude Tardif; Michal Tendera; Ph Gabriel Steg
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.